CA Stock MarketDetailed Quotes

EPRX Eupraxia Pharmaceuticals Inc

Watchlist
  • 3.700
  • +0.160+4.52%
15min DelayMarket Closed Jul 12 16:00 ET
131.80MMarket Cap-2276P/E (TTM)

Eupraxia Pharmaceuticals Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
--35.91M
5.90%19.34M
5.90%19.34M
11.46%24.43M
-47.63%14.41M
-22.12%18.26M
-22.12%18.26M
-16.95%21.92M
-5.43%27.52M
-15.83%20.75M
-Cash and cash equivalents
--35.91M
5.90%19.34M
5.90%19.34M
183.07%24.43M
6.75%14.41M
11.46%18.26M
11.46%18.26M
-67.30%8.63M
-53.61%13.5M
-45.15%13.52M
-Accounts receivable
----
----
----
--1.49K
----
----
----
----
----
----
-Other receivables
--5M
--5M
--5M
----
----
----
----
----
----
----
Total current assets
--36.22M
6.53%19.8M
6.53%19.8M
10.37%24.85M
-47.28%14.89M
-22.55%18.59M
-22.55%18.59M
-16.14%22.51M
-4.99%28.25M
-16.50%21.34M
Non current assets
-Accumulated depreciation
---413.37K
-35.95%-398.07K
-35.95%-398.07K
-39.26%-360.3K
-39.01%-341.25K
-18.68%-292.81K
-18.68%-292.81K
-15.58%-258.73K
28.27%-245.49K
14.52%-273.6K
-Long term equity investment
----
--0
--0
-99.88%8.67K
-99.42%44.6K
20.11%8.86M
20.11%8.86M
2.25%7.4M
8.00%7.65M
5,193.54%7.7M
-Other intangible assets
----
----
----
--15.96M
--13.81M
----
----
----
----
----
Regulatory assets
--167.24K
112.46%190.61K
112.46%190.61K
-76.25%67.84K
-82.33%51.65K
-73.38%89.72K
-73.38%89.72K
255.86%285.62K
795.40%292.28K
-7.74%350.15K
Total assets
--167.24K
151.39%190.61K
151.39%190.61K
59.43%58.51K
-1.59%35.19K
242.80%75.82K
242.80%75.82K
-12.92%36.7K
87.26%35.76K
-47.91%28.6K
Liabilities
Current liabilities
Current debt and capital lease obligation
--9.56M
7,951.11%10.45M
7,951.11%10.45M
8,835.96%11.33M
6,489.65%8.36M
6.93%129.82K
6.93%129.82K
6.40%126.81K
179.77%126.82K
-97.43%125.68K
-Current debt
--9.52M
12,993.65%10.4M
12,993.65%10.4M
14,279.08%11.28M
10,669.04%8.3M
6.68%79.42K
6.68%79.42K
6.44%78.42K
--77.09K
-98.43%76.03K
-Current capital lease obligation
--37.85K
5.78%53.32K
5.78%53.32K
13.67%55K
10.16%54.78K
7.32%50.4K
7.32%50.4K
6.32%48.39K
9.70%49.73K
15.26%49.64K
-Total tax payable
--0
--0
--0
-99.88%8.67K
-99.42%44.6K
20.11%8.86M
20.11%8.86M
2.25%7.4M
8.00%7.65M
5,193.54%7.7M
Current accrued expenses
--3.38M
25.32%3.03M
25.32%3.03M
87.41%2.85M
-0.01%2.66M
124.87%2.42M
124.87%2.42M
-27.97%1.52M
333.99%2.66M
-24.80%885.45K
Current liabilities
--18.53M
533.47%19.37M
533.47%19.37M
760.76%14.18M
295.26%11.02M
71.95%3.06M
71.95%3.06M
-26.14%1.65M
323.38%2.79M
-83.33%1.01M
Non current liabilities
-Long term debt
----
--0
--0
-86.29%8.67K
-70.89%23.41K
-52.51%51.3K
-52.51%51.3K
-45.60%63.29K
-40.90%80.42K
-33.57%96.67K
Non current accrued expenses
--414.85K
-14.04%456.25K
-14.04%456.25K
-13.24%422.11K
-10.61%461K
14.88%530.75K
14.88%530.75K
1.34%486.54K
128.44%515.71K
88.24%445.73K
Long term provisions
----
----
----
----
-99.72%21.19K
21.19%8.8M
21.19%8.8M
3.03%7.33M
8.96%7.57M
--7.61M
Preferred securities outside stock equity
--550.95K
67.28%858.63K
67.28%858.63K
--0
--0
-11.98%513.3K
-11.98%513.3K
--0
----
--0
Total non current liabilities
--18.53M
62.61%19.37M
62.61%19.37M
56.88%14.19M
5.97%11.06M
30.18%11.91M
30.18%11.91M
-4.44%9.05M
34.82%10.44M
40.27%8.71M
Shareholders'equity
Share capital
--116.32M
30.86%92.91M
30.86%92.91M
29.29%86.85M
5.17%74.98M
12.16%71M
12.16%71M
6.10%67.17M
9.47%71.3M
10.05%64.65M
-common stock
--116.32M
30.86%92.91M
30.86%92.91M
29.29%86.85M
5.17%74.98M
12.16%71M
12.16%71M
6.10%67.17M
9.47%71.3M
10.05%64.65M
Additional paid-in capital
--17.51M
3.92%17.51M
3.92%17.51M
----
----
55.00%16.85M
55.00%16.85M
19.49%12.48M
25.41%13.04M
31.32%11.52M
Gains losses not affecting retained earnings
---2.74M
2.86%-2.71M
2.86%-2.71M
----
----
---2.79M
---2.79M
----
----
----
Total equity
--36.64M
5.98%20.27M
5.98%20.27M
9.89%25.27M
-46.61%15.36M
-21.91%19.12M
-21.91%19.12M
-15.97%23M
-3.98%28.76M
-15.54%21.79M
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments --35.91M5.90%19.34M5.90%19.34M11.46%24.43M-47.63%14.41M-22.12%18.26M-22.12%18.26M-16.95%21.92M-5.43%27.52M-15.83%20.75M
-Cash and cash equivalents --35.91M5.90%19.34M5.90%19.34M183.07%24.43M6.75%14.41M11.46%18.26M11.46%18.26M-67.30%8.63M-53.61%13.5M-45.15%13.52M
-Accounts receivable --------------1.49K------------------------
-Other receivables --5M--5M--5M----------------------------
Total current assets --36.22M6.53%19.8M6.53%19.8M10.37%24.85M-47.28%14.89M-22.55%18.59M-22.55%18.59M-16.14%22.51M-4.99%28.25M-16.50%21.34M
Non current assets
-Accumulated depreciation ---413.37K-35.95%-398.07K-35.95%-398.07K-39.26%-360.3K-39.01%-341.25K-18.68%-292.81K-18.68%-292.81K-15.58%-258.73K28.27%-245.49K14.52%-273.6K
-Long term equity investment ------0--0-99.88%8.67K-99.42%44.6K20.11%8.86M20.11%8.86M2.25%7.4M8.00%7.65M5,193.54%7.7M
-Other intangible assets --------------15.96M--13.81M--------------------
Regulatory assets --167.24K112.46%190.61K112.46%190.61K-76.25%67.84K-82.33%51.65K-73.38%89.72K-73.38%89.72K255.86%285.62K795.40%292.28K-7.74%350.15K
Total assets --167.24K151.39%190.61K151.39%190.61K59.43%58.51K-1.59%35.19K242.80%75.82K242.80%75.82K-12.92%36.7K87.26%35.76K-47.91%28.6K
Liabilities
Current liabilities
Current debt and capital lease obligation --9.56M7,951.11%10.45M7,951.11%10.45M8,835.96%11.33M6,489.65%8.36M6.93%129.82K6.93%129.82K6.40%126.81K179.77%126.82K-97.43%125.68K
-Current debt --9.52M12,993.65%10.4M12,993.65%10.4M14,279.08%11.28M10,669.04%8.3M6.68%79.42K6.68%79.42K6.44%78.42K--77.09K-98.43%76.03K
-Current capital lease obligation --37.85K5.78%53.32K5.78%53.32K13.67%55K10.16%54.78K7.32%50.4K7.32%50.4K6.32%48.39K9.70%49.73K15.26%49.64K
-Total tax payable --0--0--0-99.88%8.67K-99.42%44.6K20.11%8.86M20.11%8.86M2.25%7.4M8.00%7.65M5,193.54%7.7M
Current accrued expenses --3.38M25.32%3.03M25.32%3.03M87.41%2.85M-0.01%2.66M124.87%2.42M124.87%2.42M-27.97%1.52M333.99%2.66M-24.80%885.45K
Current liabilities --18.53M533.47%19.37M533.47%19.37M760.76%14.18M295.26%11.02M71.95%3.06M71.95%3.06M-26.14%1.65M323.38%2.79M-83.33%1.01M
Non current liabilities
-Long term debt ------0--0-86.29%8.67K-70.89%23.41K-52.51%51.3K-52.51%51.3K-45.60%63.29K-40.90%80.42K-33.57%96.67K
Non current accrued expenses --414.85K-14.04%456.25K-14.04%456.25K-13.24%422.11K-10.61%461K14.88%530.75K14.88%530.75K1.34%486.54K128.44%515.71K88.24%445.73K
Long term provisions -----------------99.72%21.19K21.19%8.8M21.19%8.8M3.03%7.33M8.96%7.57M--7.61M
Preferred securities outside stock equity --550.95K67.28%858.63K67.28%858.63K--0--0-11.98%513.3K-11.98%513.3K--0------0
Total non current liabilities --18.53M62.61%19.37M62.61%19.37M56.88%14.19M5.97%11.06M30.18%11.91M30.18%11.91M-4.44%9.05M34.82%10.44M40.27%8.71M
Shareholders'equity
Share capital --116.32M30.86%92.91M30.86%92.91M29.29%86.85M5.17%74.98M12.16%71M12.16%71M6.10%67.17M9.47%71.3M10.05%64.65M
-common stock --116.32M30.86%92.91M30.86%92.91M29.29%86.85M5.17%74.98M12.16%71M12.16%71M6.10%67.17M9.47%71.3M10.05%64.65M
Additional paid-in capital --17.51M3.92%17.51M3.92%17.51M--------55.00%16.85M55.00%16.85M19.49%12.48M25.41%13.04M31.32%11.52M
Gains losses not affecting retained earnings ---2.74M2.86%-2.71M2.86%-2.71M-----------2.79M---2.79M------------
Total equity --36.64M5.98%20.27M5.98%20.27M9.89%25.27M-46.61%15.36M-21.91%19.12M-21.91%19.12M-15.97%23M-3.98%28.76M-15.54%21.79M

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg